Dividend ABT - Dividend Information for Abbott Laboratories

Bookmark Page
February 07, 2012 - 04:38 AM PST


dividend screener	email page \| print

You are here: Screening > NYSE > MAJOR PHARMACEUTICALS > Abbott Laboratories (ABT)
Last: 55.39 As of: Feb 06, 2012	Change: 0.94 (1.73%)	Open: 54.74	High: 55.45	Low: 54.67
	Prev: 54.45	Volume: 8,096,300	Earnings Per Share: 3.01	Dividend Yield: 3.53%
	Ex Date: Oct 12, 2011	Record Date: Oct 14, 2011	Payable Date: Nov 15, 2011	Dividend Per Share: 0.480

chart ABT - Abbott Laboratories
dividend

Chart: Timeframe and Display
Period:		Frequency:		Chart Type:		Show Dividends:

Historical Prices

Dividends

Date	Open	High	Low	Close	Volume
Feb 06, 2012	54.74	55.45	54.67	55.39	8,096,300
Feb 02, 2012	54.24	54.56	53.96	54.45	9,189,100
Feb 01, 2012	54.19	54.50	54.04	54.26	14,027,100
Jan 31, 2012	54.57	54.75	53.96	54.15	12,417,500
Jan 30, 2012	54.63	54.68	54.07	54.47	9,637,200
Jan 27, 2012	54.88	55.23	54.70	55.02	6,391,800
Jan 26, 2012	55.45	55.45	54.73	54.87	7,284,300
Jan 25, 2012	55.13	55.45	54.66	55.23	12,213,500
Jan 24, 2012	55.70	55.99	55.70	55.98	7,567,900
Jan 23, 2012	55.86	55.87	55.47	55.72	5,828,400

Ex Date	$ Amount
2011
Oct 12, 2011	0.480
Jul 13, 2011	0.480
Apr 13, 2011	0.480
Jan 12, 2011	0.440
2010
Oct 13, 2010	0.440
Jul 13, 2010	0.440
Apr 13, 2010	0.440
Jan 13, 2010	0.400
2009
Oct 13, 2009	0.400
Jul 13, 2009	0.400
Apr 13, 2009	0.400
Jan 13, 2009	0.360
2008
Oct 10, 2008	0.360
Jul 11, 2008	0.360
Apr 11, 2008	0.360
Jan 11, 2008	0.325
2007
Oct 11, 2007	0.325
Jul 11, 2007	0.325
Apr 11, 2007	0.325
Jan 10, 2007	0.295
2006
Oct 11, 2006	0.295
Jul 12, 2006	0.295
Apr 11, 2006	0.295
Jan 11, 2006	0.275
2005
Oct 12, 2005	0.275
Jul 13, 2005	0.275
Apr 13, 2005	0.275
Jan 12, 2005	0.260
2004
Oct 13, 2004	0.260
Jul 13, 2004	0.260
Apr 13, 2004	0.260
Jan 13, 2004	0.245
2003
Oct 10, 2003	0.245
Jul 11, 2003	0.245
Apr 11, 2003	0.245
Jan 13, 2003	0.235
2002
Oct 11, 2002	0.235
Jul 11, 2002	0.235
Apr 11, 2002	0.235
Jan 11, 2002	0.210
2001
Oct 11, 2001	0.210
Jul 11, 2001	0.210
Apr 10, 2001	0.210
Jan 10, 2001	0.190
2000
Oct 11, 2000	0.190
Jul 12, 2000	0.190
Apr 12, 2000	0.190
Jan 12, 2000	0.170
1999
Oct 13, 1999	0.170
Jul 13, 1999	0.170
Apr 13, 1999	0.170
Jan 13, 1999	0.150

More Historical Data >

Related News

After Vodafone stake buy, Piramal to rely on borrowings
Reuters India - Feb 6, 2012
By Kaustubh Kulkarni and Archana Narayanan | MUMBAI (Reuters) - Piramal Healthcare Ltd will rely on borrowings for future buys and investments as it will finish its cash pile after raising stake in mobile operator Vodafone's India unit, senior company ...
Abbott, Hospira Win Appellate Affirmation in Spinoff Retirement Lawsuit
Bloomberg - Feb 3, 2012
Abbott Laboratories and Hospira Inc. (HSP) won a US appeals court ruling upholding a trial court finding the companies didn't mislead workers about retirement benefit levels to induce them to leave Abbott for its Hospira spinoff.
What Abbott Needs Now: A New CEO
Investorplace.com - Feb 2, 2012
Abbott Laboratories (NYSE:ABT) is among the prominent drug companies that announced a divestiture in 2011. But now that it has split off its prescription pharmaceutical business into a separate firm, it may be a good move for the surviving company to ...
GlaxoSmithKline Poised To Break 52-Week High
Seeking Alpha - Jan 31, 2012
Let's examine the fundamental reasons first, then the chart technicals for why I think GlaxoSmithKline (GSK) looks poised to break to a new 52-week high.
Glaxo, Lilly, Pfizer Said to Be Interested in Turkey's MN Pharma
Bloomberg - Jan 31, 2012
GlaxoSmithKline Plc (GSK), Eli Lilly & Co. and Pfizer Inc. (PFE) are among about half a dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in a deal that may value the Turkish drugmaker at $1 billion, three people with ...
Turkish drugmaker wooed by GSK, Pfizer, Bloomberg says - FiercePharma
FDA Approves Kalydeco to Treat Rare Form of CF; Glaxo, Lilly, Pfizer Said to ... - BioMedReports (subscription)
Abbott Laboratories Tests New Technical Support Levels
AVAFIN - Jan 30, 2012
NEW YORK (AVAFIN) -- Abbott Laboratories shares closed below the 50-day moving average of $54.86. If prices remain below this level, technical analysts will assess this development as a sign of weakness.
DNDi And Abbott Laboratories Expand Partnership To Boost Innovation for Neglected Tropical Diseases
Reuters Key Development - Jan 30, 2012
Zacks Investment Research Analysts Reiterate a "Neutral" Rating on Abbott ...
LocalizedUSA - Jan 27, 2012
Abbott Laboratories (NYSE: ABT)'s stock had its “neutral” rating reaffirmed by Zacks Investment Research in a note issued to investors on Friday.
Abbott Laboratories Reports Strong Earnings Results - NYSE:ABT - Galaxy Stocks
5 Short Sighted Stock Spinoffs
Forbes - Jan 27, 2012
Divestitures became a major 2011 strategy as some of America's biggest blue chip stocks like Kraft Foods (KFT), ConocoPhillps (COP), Abbott Laboratories (ABT), Northrop Grumman (NOC), Tyco (TYC) and Marathon Oil (MRO) spun assets to unlock value in ...
Volume Spike Detected in Shares of Abbott Laboratories as They Move Lower on ...
Financial News Network Online - Jan 25, 2012
Abbott Laboratories shares are trading on heavy volume today, having fallen 2.2% to $54.74. About 8.3 million shares have been traded today, as compared to the 30-day average volume of 6.3 million shares.

The following links are external and they open inside of a new browser window. Please double check your pop-up blocker settings.
Yahoo Finance	Earnings.com	CBS MarketWatch	Google Finance


dividend screener	email page \| print

Display companies starting with the letter:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Disclaimer:

Information reflected from corresponding markets at the time of publication. Any information here should always be independently verified. MarketShuttle will not be liable for any loss or damage caused by a reader's reliance on information obtained on our Web Site.

Historical and symbol pricing data and daily updates provided by eod data.
Dividend fundamentals data provided by EDI.

my account | contact us | search | home